WisdomTree U.S. MidCap Quality Growth Fund (QMID)

On our desk, looking at QMID's asset under management sitting right around $2.2 million with sparse average daily volume, the institutional footprint is extremely quiet. We saw only three institutional holders in Q2 2026, with some existing positions getting trimmed. While the 0.38% expense ratio is standard for a smart-beta factor strategy, the lack of immediate liquidity and a relatively narrow 124 to 126 stock holding count means execution requires patience. Until secondary market volume scales up significantly, larger allocators are going to stay on the sidelines watching from afar.

From a quantitative risk perspective, Morningstar flags QMID with a portfolio risk score of 82, classifying it as very aggressive. The trailing data shows a standard deviation of 19.15 alongside a 3-year/5-year/10-year tracking profile that currently trails standard category averages. Even though it holds a quantitative Bronze Medalist rating emphasizing a repeatable process pillar, the performance gap against standard benchmarks like the SandP MidCap 400 Growth Index—where QMID's 1-year return sits near 10.30% versus the index's 30.01%—highlights a substantial tracking and style divergence that risk committees must account for.

When evaluating QMID's underlying mechanics for factor rotation models, my technical protocol focuses strictly on how its tracking index selects for quality and growth. The fund tracks the WisdomTree U.S. MidCap Quality Growth Index with a 30-day SEC yield around 0.33% and a distribution yield near 0.49%. In our strategy reviews, we note that while the quantitative rules-based filtering aims to isolate fundamentally sound mid-caps, the realized YTD NAV return of roughly 4.04% as of mid-2026 indicates that factor performance has lagged behind broader cyclical mid-cap growth. Analysts should closely monitor upcoming reconstitution dates to see if factor adjustments narrow this performance spread.